Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis.
Blood Adv
; 7(15): 3984-3992, 2023 08 08.
Article
in En
| MEDLINE
| ID: mdl-36857436
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Histiocytosis, Sinus
/
Erdheim-Chester Disease
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2023
Document type:
Article
Country of publication: